Israel's rate of vaccinations has seen a sharp pickup. The
Netherlands, Norway, Portugal, Saudi Arabia, Singapore and Spain are
all vaccinating at their fastest speed to date. Belgium, Denmark,
Finland and Sweden are not far behind.
But it is a different story in the United States. At its current,
declining pace, 70% of the U.S. population will not receive a first
dose of vaccine until Dec. 1, according to the Reuters analysis of
Our World in Data vaccination figures https://ourworldindata.org/covid-vaccinations.
At the current pace, Canada, Chile, the United Kingdom, and eight
others will reach that benchmark before the end of the month. And if
the current pace is maintained, five more countries will hit 70% by
the end of August. Those dates could change depending on many
factors, including approvals to vaccinate younger children. (Graphic
on vaccinations) https://tmsnrt.rs/2TbE5vy
VACCINATION BURNOUT?
In Israel the vaccination rate had plateaued in April as new COVID
infections were on a months-long steady decline. But when the
arrival of Delta brought a spike of cases in June, the government
jumped in quickly with a new campaign urging teenagers to get the
shot and parents to vaccinate their children aged 12 to 15.
In many countries, vaccination drives slowed before reaching 70% or
more of the population - a threshold some experts say could help
largely curb COVID-19 transmission through so-called herd immunity,
when combined with people who developed immunity following an
infection. (Graphic on global vaccinations) https://tmsnrt.rs/3tUM8ta
The ability of the coronavirus to mutate quickly into new variants,
such as Delta, that reduce the effectiveness of vaccines has cast
doubt on whether herd immunity can be achieved. However, various
governments have still set national vaccination goals close to that
number to encourage citizens to get inoculated. The European Union,
for instance, has distributed enough vaccines for 70% of its
population.
In some places, regulators have just recently authorized use of the
shots in 12 to 15 year olds; in others, supply is catching up with
demand.
Many of those countries had initially focused on giving shots to
older populations and other high-risk groups. The Pfizer/BioNTech
vaccine has been authorized by the U.S. and European Union for
people aged 12 and over, but others such as AstraZeneca are only
available to adults.
With the spread of the Delta variant, countries are trying to
reignite their campaigns by overcoming skepticism about the vaccine
and misconceptions that the young do not need a shot.
Heidi Larson, director of the international Vaccine Confidence
Project and a professor at the London School of Hygiene and Tropical
Medicine, said a rise in vaccinations due to Delta variant concerns
may have been held back by changes seen as signalling an end to the
pandemic, such as lifting mask mandates and travel bans.
"We're giving a lot of mixed messages right now," Larson said.
Israel is an exception, she said. It has reimposed measures such as
requiring mask use indoors.
While a decline in vaccination rates is to be expected, it has
created pockets where groups including children, the elderly and
homeless remain at risk, experts say.
"A deceleration of vaccination in itself is a logical phenomenon,"
said Vincent Marechal, a senior virologist with France's Sorbonne
University. But slowing down too early opens the door to the virus
spreading - mostly among children - and evolving to become more
dangerous for them.
[to top of second column] |
THE YOUNG DRIVE GAINS
Portugal, where the Delta variant accounts for
more than 90% of cases, has the highest number
of new cases in the European Unions since
mid-June. It has also doubled its pace of
vaccinations from a low of around 60,000
inoculations per day, in part by including 18 to
29 year olds. (Graphic on global cases) https://tmsnrt.rs/34pvUyi
In Singapore, the rate of vaccinations has recently gone up after
opening its vaccination program to people aged 12 to 39 years old.
It also hastened the delivery of vaccine supplies to help it
accelerate the rollout.
In Britain, where 87% of adults have received at least one dose of
COVID-19 vaccine, the government stepped up its target to have all
adults vaccinated by July 19, when its COVID restrictions are slated
to be lifted. It has begun giving second shots sooner as well to
fight the Delta variant.
NO MAGICAL SOLUTION
In France, where 53.3% of the adult population has received one dose
of a vaccine and 41.3% two doses or a single-dose shot, authorities
are ramping up outreach to those who have not made vaccination
appointments.
"We are indeed hitting a glass ceiling and trying to come up every
day with ideas, and the good news is we are seeing a very recent
pick up in bookings," a source close to the health ministry said
last week.
The source added the government was still hoping to see 40 million
of adults receive a first dose by the end of August versus 35.9
million as of July 12.
France is about to open temporary vaccination centres at cultural
venues across the country such as in Avignon, home to a world-famous
theatre festival, and vaccination buses will tour the Bordeaux wine
region of Gironde to catch seasonal workers.
COVID-19 jabs will be mandatory for France's health workers and
anyone wanting to get into a cinema or board a train will soon need
to show proof of vaccination or a negative test under new rules
announced by President Emmanuel Macron on Monday.
In the United States, where young people have been eligible since
April, vaccinations are stagnant. The Biden administration missed
its goal of 70% of adults having had at least one COVID-19 shot by
July 4 and has struggled to reach 50% fully vaccinated even as it
has warned of outbreaks due to the Delta variant.
Younger people have lagged older ones in seeking vaccines while
shots among Black and Hispanic Americans have trailed those of Asian
and white Americans, according to data from the Centers for Disease
Control and Prevention.
"Whether governments throw in incentives or coercive measures, there
is no magical solution," said Martin Blachier, an epidemiologist
with Paris-based healthcare data analysis firm Public Health
Expertise. "Some will just not get the vaccine."
(Reporting by Matthias Blamont in Paris, Michael Erman in New York
and Maayan Lubell in Jerusalem; Additional reporting by Francesco
Guarascio in Brussels, Nikolaj Skydsgaard in Copenhagen, Sergio
Goncalves in Lisbon, Alistair Smout in London, Lin Chen in
Singapore, Chris Canipe in Kansas City, Missouri, Jitesh Chowdhury
in Bengalaru; editing by Jon McLure, Caroline Humer and Lisa
Shumaker)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |